TITLE

FDA issues Multiple Drug Warnings

PUB. DATE
August 2011
SOURCE
Travel Medicine Advisor;Aug2011 Supplement, p1
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The August 2011 issue of the journal "Pharmacology Watch," is presented. It discusses the multiple drug safety warnings from the U.S. Food and Drug Administration. It offers information on the study conducted by FDA on the possible link between angiotensin receptor blockers (ARBs) and cancer. It also mentions the FDA's approval to the first generic version of levofloxacin, also known as Levaquin.
ACCESSION #
63534854

 

Related Articles

  • Manufacturer Removes Remaining Stocks of Trasylol From The U.S. Market.  // Pharmaceutical Processing;Jun2008, Vol. 23 Issue 6, p29 

    The article reports on the notification of the Food and Drug Administration (FDA) about the removal of the remaining Trasylol stock of Bayer HealthCare Pharmaceuticals Inc. from the U.S. market. FDA will work with the company to ensure a smooth and complete process. It discusses that the drug is...

  • New Strategy Could Reduce Animal-Based Cancer Tests. Sullivan, Kristie // Good Medicine;Summer2010, Vol. 19 Issue 3, p4 

    The article reports on the potential adoption of a new strategy by the U.S. Food and Drug Administration (FDA) that could reduce the use of animals in cancer tests in June 2010.

  • Vivus, Orexigen Jump on CV Data, but No Obesity Win Yet. Boggs, Jennifer // BioWorld Today;4/5/2011, Vol. 22 Issue 65, p1 

    The article reports on share gains posted by Vivus Inc. and Orexigen Therapeutics Inc. on April 4, 2011 in response to cardiovascular data presented for obesity candidates at the American College of Cardiology (ACC) meeting. A long-term data from Vivus found that patients treated with Qnexa...

  • Actemra poised to launch IL-6 inhibitors. Melton, Lisa; Coombs, Amy // Nature Biotechnology;Sep2008, Vol. 26 Issue 9, p957 

    The article discusses the U.S. Food and Drug Administration's decision to support the Swiss pharmaceutical company Roche in using the humanized monoclonal antibody (mAb) Acterma to treat rheumatoid arthritis. This would be a major shift in how biologics have traditionally been used to treat...

  • Prescription ads next on FDA list. Colford, S.W. // Advertising Age;8/26/91, Vol. 62 Issue 35, p32 

    Examines Food & Drug Administration (FDA) plans to tighten regulations on drug advertising and various promotional practices. Principal concerns of Commissioner David Kessler; Present regulations of consumer ads for prescription drugs.

  • Over-the-counter drugs. Sommi Jr., R.W. // Current Health 2;May92, Vol. 18 Issue 9, p21 

    Discusses the differences between prescription and nonprescription drugs (also called over-the-counter, or OTC, drugs). Role of the US Food and Drug Administration (FDA); OTC drugs for self-limiting illnesses such as the common cold; The FDA's concern about side effects, clear instructions and...

  • The FDA safeguarding. Kowalski, Kathiann M. // Current Health 2;Jan1996, Vol. 22 Issue 5, p20 

    Presents the work and duties of the Food and Drug Administration (FDA) in the United States. Origin of the agency; Rules followed on food standard inspection; Presence of food chemicals; Safety programs of FDA; Actions of the agency in the presence of problems; Nutrition labeling and Education...

  • Product testing.  // Current Health 1;May92, Vol. 15 Issue 9, p22 

    Discusses the medicine and product testing conducted by the US Food and Drug Administration (FDA). Pharmaceutical tests; How the FDA studies test results; FDA approval; Drug testing in other countries; Tests on food, cosmetics, pesticides; The FDA's concern about food labels; Testing donated blood.

  • Dateline Washington.  // Consumers' Research Magazine;Feb1993, Vol. 76 Issue 2, p6 

    Reports that in January a US District Court judge ruled that the Food and Drug Administration (FDA) is not responsible for $210 million worth of losses incurred by Chilean fruit growers when in 1989, the FDA temporarily banned sales of grapes to the United States. Details of the ruling.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics